Clinical Evaluation of Siddha Medicine thuthuvelai chooranam for swasakasam (Bronchial asthma)

Phase II non randomized open clinical evaluation of siddha medicine thuthuvelai chooranam for the management of swasakasam (Bronchial asthma) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060017

Enrollment

Registered

2023-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

Intervention1: Thuthuvelai chooranam: 650mg, bd after food with honey for 48 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Cough with tenacious sputum, Dyspnoea, H/O Wheeze or without wheeze,Chest tightness,Peak expiratory flow rate below 60%

Exclusion criteria

Exclusion criteria: Chronic bronchitis Bronchiectasis Bronchogenic carcinoma Pulmonary TB Congestive cardiac failure Bleeding disorders Pregnancy and lactating mothers Status asthmaticus Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Outcome will be by assessing peak expiratory flow rate above 60%Timepoint: 48 days	—

Secondary

Measure	Time frame
reduction in clinical symptoms like wheeze, dyspnoea and chest tightness.Timepoint: 48 days	—

Countries

India

Contacts

Public ContactDrMAnitha

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026